Spots Global Cancer Trial Database for Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer
Official Title: Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer
Study ID: NCT00826579
Conditions
Study Description
Brief Summary: The study is a feasibility and validation study of the sentinel lymph node (SLN) procedure in all stages of colon cancer. If the SLN can be reliably identified, it could be submitted to a more accurate histopathological examination (multiple sections, special staining). The detection of micrometastases in the SLN (occult stage III, upstaging) is possible. Patients with micrometastases should be considered at higher risk. Additionally, a search for occult metastatic tumor cells in the bone marrow is performed.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Carsten T. Viehl, MD, Basel, , Switzerland
Urban Laffer, MD, Biel, , Switzerland
Markus Zuber, MD, Olten, , Switzerland
Contact Details
Name: Carsten T. Viehl, MD
Affiliation: aktuell: Spitalzentrum Biel-Bienne
Role: PRINCIPAL_INVESTIGATOR
Name: Markus Zuber, MD
Affiliation: Kantonsspital Olten
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
